Pharnext and the University Hospital Institute Méditerranée Infection Announce a Joint Effort to Evaluate Repurposed Drugs for Potential Use Against the COVID-19 Virus
Rapid in vitro testing of repurposed drug candidates identified by Pharnext's PLEOTHERAPYTM Artificial Intelligence platformPARIS, France, 8:00am, April 22, 2020 (CET) - Pharnext SA...